{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:39:19Z","timestamp":1783708759586,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cranio-Maxillofacial Surgery"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jcms.2017.01.013","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T12:48:38Z","timestamp":1485348518000},"page":"570-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Clinical course and therapeutic outcomes of operatively and non-operatively managed patients with denosumab-related osteonecrosis of the jaw (DRONJ)"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0017-4575","authenticated-orcid":false,"given":"Sebastian","family":"Hoefert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelheid","family":"Munz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Elayouti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegmar","family":"Reinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcms.2017.01.013_bib1","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/jcb.23164","article-title":"Apoptotic osteocytes regulate osteoclast precursor recruitment and differentiation in\u00a0vitro","volume":"112","author":"Al-Dujaili","year":"2011","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jcms.2017.01.013_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/TCRM.S24239","article-title":"Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab","volume":"8","author":"Anastasilakis","year":"2012","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jcms.2017.01.013_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.joms.2008.12.002","article-title":"Imaging findings in bisphosphonate-related osteonecrosis of jaws","volume":"67","author":"Arce","year":"2009","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.01.013_bib4","first-page":"122","article-title":"Arzneimittelinformation If: Divertikulitis unter Denosumab (PROLIA)","volume":"45","year":"2014","journal-title":"Arznei-telegramm"},{"key":"10.1016\/j.jcms.2017.01.013_bib5","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jcms.2017.01.013_bib6","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A\u00a0single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jcms.2017.01.013_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/clr.12556","article-title":"Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials","volume":"27","author":"Boquete-Castro","year":"2016","journal-title":"Clin Oral Implant Res"},{"key":"10.1016\/j.jcms.2017.01.013_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.14219\/jada.archive.2012.0323","article-title":"Denosumab-related osteonecrosis of the jaw","volume":"143","author":"Diz","year":"2012","journal-title":"J\u00a0Am Dent Assoc"},{"key":"10.1016\/j.jcms.2017.01.013_bib9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000368844","article-title":"Side effects of bone-targeted therapies in advanced breast cancer","volume":"9","author":"Domschke","year":"2014","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.jcms.2017.01.013_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJM200507073530120","article-title":"Osteonecrosis of the jaw and bisphosphonates","volume":"353","author":"Durie","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcms.2017.01.013_bib11","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/j.oooo.2012.01.046","article-title":"Review of current literature and implications of RANKL inhibitors for oral health care providers","volume":"116","author":"Epstein","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jcms.2017.01.013_bib12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jcms.2017.01.013_bib13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.oooo.2014.04.017","article-title":"Bisphosphonate-induced osteonecrosis of the jaws: clinical, imaging, and histopathology findings","volume":"118","author":"Franco-Pretto","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jcms.2017.01.013_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1359\/jbmr.081113","article-title":"Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing","volume":"24","author":"Gerstenfeld","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2017.01.013_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1399-302X.2008.00494.x","article-title":"Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria","volume":"24","author":"Han","year":"2009","journal-title":"Oral Microbiol Immunol"},{"key":"10.1016\/j.jcms.2017.01.013_bib16","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1259\/bjr\/99102700","article-title":"Skeletal complications of bisphosphonate use: what the radiologist should know","volume":"85","author":"Haworth","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jcms.2017.01.013_bib17","doi-asserted-by":"crossref","first-page":"e88481","DOI":"10.1371\/journal.pone.0088481","article-title":"Alterations of mass density and 3D osteocyte lacunar properties in bisphosphonate-related osteonecrotic human jaw bone, a synchrotron microCT study","volume":"9","author":"Hesse","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcms.2017.01.013_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jmi.12147","article-title":"Accessing osteocyte lacunar geometrical properties in human jaw bone on the submicron length scale using synchrotron radiation muCT","volume":"255","author":"Hesse","year":"2014","journal-title":"J\u00a0Microsc"},{"key":"10.1016\/j.jcms.2017.01.013_bib19","doi-asserted-by":"crossref","first-page":"452737","DOI":"10.1155\/2014\/452737","article-title":"Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary","volume":"2014","author":"Hinson","year":"2014","journal-title":"Int J Dent"},{"key":"10.1016\/j.jcms.2017.01.013_bib20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1055\/s-0032-1331687","article-title":"Prothesendruckstellen als ein Risiko einer Bisphsophonat-assoziierten Kiefernekrose","volume":"121","author":"Hoefert","year":"2012","journal-title":"ZWR"},{"key":"10.1016\/j.jcms.2017.01.013_bib21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.joms.2010.06.200","article-title":"Relevance of a prolonged preoperative antibiotic regime in the treatment of bisphosphonate-related osteonecrosis of the jaw","volume":"69","author":"Hoefert","year":"2011","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"6","key":"10.1016\/j.jcms.2017.01.013_bib22","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00784-014-1358-3","article-title":"Zoledronate but not denosumab suppresses macrophagic differentiation of THP-1 cells. An aetiologic model of bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"19","author":"Hoefert","year":"2015","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jcms.2017.01.013_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00784-009-0300-6","article-title":"Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings","volume":"14","author":"Hoefert","year":"2010","journal-title":"Clin Oral Investig"},{"issue":"2","key":"10.1016\/j.jcms.2017.01.013_bib24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00784-014-1273-7","article-title":"Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases","volume":"19","author":"Hoefert","year":"2015","journal-title":"Clin Oral Investig"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.jcms.2017.01.013_bib25","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1007\/s40520-013-0086-x","article-title":"Effects of denosumab on cortical and trabecular microarchitecture: evidences from clinical studies","volume":"25","author":"Iolascon","year":"2013","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jcms.2017.01.013_bib26","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0022034515572021","article-title":"Infection and medication-related osteonecrosis of the jaw","volume":"94","author":"Katsarelis","year":"2015","journal-title":"J\u00a0Dent Res"},{"key":"10.1016\/j.jcms.2017.01.013_bib27","first-page":"397","article-title":"Frequency and location of traumatic ulcerations following placement of complete dentures","volume":"20","author":"Kivovics","year":"2007","journal-title":"Int J Prosthodont"},{"key":"10.1016\/j.jcms.2017.01.013_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jcms.2017.01.013_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00784-015-1550-0","article-title":"Mouse anti-RANKL antibody delays oral wound healing and increases TRAP-positive mononuclear cells in bone marrow","volume":"20","author":"Kuroshima","year":"2016","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.jcms.2017.01.013_bib30","first-page":"784348","article-title":"Imaging findings of bisphosphonate-related osteonecrosis of the jaws: a critical review of the quantitative studies","author":"Leite","year":"2014","journal-title":"Int J Dent"},{"key":"10.1016\/j.jcms.2017.01.013_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.oooo.2012.08.439","article-title":"The relationship of denosumab pharmacology and osteonecrosis of the jaws","volume":"114","author":"Malan","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jcms.2017.01.013_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3892\/mco.2015.696","article-title":"Denosumab-associated osteonecrosis of the jaw affects osteoclast formation and differentiation: pathological features of two cases","volume":"4","author":"Matsushita","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.jcms.2017.01.013_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpor.2014.08.001","article-title":"Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab","volume":"59","author":"Niibe","year":"2015","journal-title":"J\u00a0Prosthodont Res"},{"key":"10.1016\/j.jcms.2017.01.013_bib34","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/adj.12217","article-title":"Denosumab and osteonecrosis of the jaws \u2013 the pharmacology, pathogenesis and a report of two cases","volume":"59","author":"O'Halloran","year":"2014","journal-title":"Aust Dent J"},{"key":"10.1016\/j.jcms.2017.01.013_bib35","first-page":"621","article-title":"Healing of osteonecrosis of the jaw (ONJ) after discontinuation of denosumab in a patient with bone metastases of colorectal cancer: a case report and hypothesis","volume":"46","author":"Ohga","year":"2015","journal-title":"Quintessence Int"},{"issue":"3","key":"10.1016\/j.jcms.2017.01.013_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/clr.12538","article-title":"Influence of osteoporosis on the osteocyte density of human mandibular bone samples: a controlled histological human study","volume":"27","author":"Oliveira","year":"2016","journal-title":"Clin Oral Implant Res"},{"issue":"3","key":"10.1016\/j.jcms.2017.01.013_bib37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcms.2015.12.005","article-title":"Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: a series of thirteen patients","volume":"44","author":"Owosho","year":"2016","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2017.01.013_bib38","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1016\/j.jcms.2012.10.014","article-title":"Denosumab osteonecrosis of the mandible: a new entity? A case report","volume":"41","author":"Pichardo","year":"2013","journal-title":"J\u00a0Craniomaxillofac Surg"},{"key":"10.1016\/j.jcms.2017.01.013_bib39","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1002\/jbmr.149","article-title":"Effects of denosumab on bone histomorphometry: the FREEDOM and STAND studies","volume":"25","author":"Reid","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2017.01.013_bib40","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.01.013_bib41","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.joms.2015.09.024","article-title":"Disease stage and mode of therapy are important determinants of treatment outcomes for medication-related osteonecrosis of the jaw","volume":"73","author":"Ruggiero","year":"2015","journal-title":"J\u00a0Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.01.013_bib42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcms.2017.01.013_bib43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1402.089","article-title":"Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy","volume":"1117","author":"Russell","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcms.2017.01.013_bib44","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcms.2017.01.013_bib45","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/jbmr.81","article-title":"Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate","volume":"25","author":"Seeman","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.jcms.2017.01.013_bib46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-RANK ligand therapy","volume":"48","author":"Taylor","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.jcms.2017.01.013_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1601-0825.2008.01494.x","article-title":"Dental panoramic radiographic evaluation in bisphosphonate-associated osteonecrosis of the jaws","volume":"15","author":"Treister","year":"2009","journal-title":"Oral Dis"},{"key":"10.1016\/j.jcms.2017.01.013_bib48","first-page":"2035","article-title":"RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem?","volume":"19","author":"Van den Wyngaert","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jcms.2017.01.013_bib49","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00198-011-1755-2","article-title":"Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?","volume":"23","author":"Watts","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jcms.2017.01.013_bib50","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1592\/phco.31.5.510","article-title":"Effects of denosumab on bone mineral density and bone turnover in postmenopausal women","volume":"31","author":"Wensel","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jcms.2017.01.013_bib51","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.oooo.2012.08.458","article-title":"Prevalence of cone beam computed tomography imaging findings according to the clinical stage of bisphosphonate-related osteonecrosis of the jaw","volume":"114","author":"Wilde","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jcms.2017.01.013_bib52","first-page":"125","article-title":"Pseudoepitheliomatous hyperplasia associated with bisphosphonate-related osteonecrosis of the jaw","volume":"28","author":"Zustin","year":"2014","journal-title":"In\u00a0Vivo"}],"container-title":["Journal of Cranio-Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518217300240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1010518217300240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T14:35:44Z","timestamp":1760884544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010518217300240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1010518217300240"],"URL":"https:\/\/doi.org\/10.1016\/j.jcms.2017.01.013","relation":{},"ISSN":["1010-5182"],"issn-type":[{"value":"1010-5182","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical course and therapeutic outcomes of operatively and non-operatively managed patients with denosumab-related osteonecrosis of the jaw (DRONJ)","name":"articletitle","label":"Article Title"},{"value":"Journal of Cranio-Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcms.2017.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}